Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights.

So let’s get straight to the point.

Analyst are offering a sophisticated market intelligence report for the stem cell research supply market.

Whether
supply stem cell research products or wish to expand product line, know just how essential and lucrative this
market is. want to make effective product development
decisions, to sell more effectively to scientists, to generate improved
revenues and take market share from competition.

This report –
published in May 2014 – shows how to do just that, helping understand the prevailing market conditions and giving guidance to
strategically position and develop stem cell product lines.

So when choose our industry-leading market report, gaining a competitive advantage in three core areas.

1. Understanding what customers are thinking

A
key component of this report is a survey of the very people creating products for. The data gives an intimate insight into the
minds of hundreds of research scientists – both domestic and
international – working specifically in the stem cell sector.

This
expert market intelligence allows to more profitably focus research and development budget. With a deeper understanding of the
needs of customers, intelligent product development is the
inevitable result. This means develop more successful products
and minimize unprofitable R&D spending.

And, with access
to the latest stem cell product research, able to take
advantage of new opportunities before competitors are even aware of
them.

2. Market to these customers more effectively

Just
as focus R&D spending on products with the greatest
potential, so too can ensure marketing dollars work harder and
smarter. With the insights and depth of market data contained in this
report can position products to maximize revenue:

Reduce marketing spending

Improve ROI for marketing dollars spent

Increase response rates

By
understanding the current and future needs of customer base can focus marketing efforts on the most profitable products, in the
most promising research areas and within the most lucrative domestic
and international markets.

Analyst are witnessing an explosion in the value of the stem cell market, and that means more and more competitors .

As
a forward-thinking leader, not satisfied with maintaining a
piece of this ballooning market – want to dominate it. Of course, competitors are no different and they’re planning to muscle out
of the game.

So sitting still will leave behind. Our report
allows to do the opposite: to take decisive action, to innovate and
to lead.

So avoid the shrinking revenues and squeezed margins that
come from increased competition. Absorb this report and make decisions
with confidence.

Learn the key strengths of competitors

Intelligently position products to fill gaps in the market

Understand crucial trends to stay ahead of competition.

Tracking stem cell market trends, so don’t have to

Analyst have quantified and assessed the critical trends in the stem cell
marketplace, ensuring all information is up-to-date. This means able to focus product development and marketing activity in exactly
the right place to beat competition. Analyst compile and analyze data
from a broad range of sources, including:

Stem cell grant funding

Stem cell patents

Stem cell publications

Stem cell product launches

New entrants to the market

International surveys

Not only do analyst measure these trends, but analyst also break the data down by stem cell types.

Analyst are loyal to the data and year on year invest heavily in the best data
mining and analysis tools. Couple this with our unrivaled knowledge of
the stem cell product marketplace, and this report is a road map to success.

Why is this report different from others available?

It’s
quite simple. Our report does not look at the whole stem cell industry
as if it was one marketplace, a mistake that every other stem cell
report makes. As anyone working with stem cells knows, the stem cell
market has two very distinct parts: stem cell therapies (the clinical
applications of stem cells for medical purposes) and stem cell research
products (the research tools and reagents that are used by scientists).

It’s
the research products market are interested in. So this entire
report is geared toward helping achieve success in developing and
marketing stem cell research products.

What does this means for business?

These
industry insights will allow to dramatically increase profits in
the stem cell sector. And discover a game-changing focus in marketing and R&D budgets.

However, a word of warning: the
report alone will not change business. But in the hands of a smart
and innovative leader, this exclusive information allows capture a
larger slice of a highly profitable market. A market that will only
continue to grow.

The better the information , the better
the decisions. So instead of relying only on past
performance indicators and incomplete market data, gain the full picture
of the stem cell product market through one insightful and up-to-date
source.

A market with a billion dollars “up for grabs”

The
growth in research into stem cells has exploded in the past decade. And
so the market to supply stem cell research products has grown to meet
this huge demand.

There are now over one million stem cell researchers worldwide.

There
were 17 companies when analyst first started monitoring the stem cell
research products market in 2004. This has risen to more than 100
companies today, a 6-fold increase.

Full-year 2013 analysis
determines the size of the stem cell research products market (including
stem cell antibodies) to be $3.22 billion, and the stem cell therapies
market to be $3.31 billion, for a total of $6.53 billion.

The
potential of stem cell research in modern medicine is truly staggering.
And when the answers to some of our most challenging health problems
are within reach, this market is only going to get
bigger and more attractive. This is a rapid growth industry.

Precision Valuations, by Market Segment

The report identifies, defines, and quantifies each market segment within the stem cell product industry, including:

Accurately produce market valuations without characterizing each
segment of the stem cell product market. Our specialized knowledge of
the industry means Get accurate, precise valuations for every
segment of the market - including the ones that matter most to business.

Analyst know the stem cell industry inside and out.

It
means analyst understand the current and future product trends more
intimately than any other company. When analyst say a global leader in
stem cell industry data, it’s not marketing hype.

Executive Summary

Stem
cells are primitive cells found in all multi-cellular organisms that
are characterized by self-renewal and the capacity to differentiate into
any mature cell type.

Stem cells are still a relatively new
discovery, as the first mouse embryonic stem cells were derived from
embryos in 1981, but it was not until 1995 that the first successful
culturing of embryonic stem cells from non-human primates occurred and
not until November 1998 that a technique was developed to isolate and
grow embryonic stem cells from human blastocysts. In 2006, induced
pluripotent stem cells were produced for the first time from mouse cells
and in 2007 they were produced from human cells. Furthermore, it was
not until 2008 that the first full transplant of a human organ grown
from adult stem cells was performed when a section of trachea was
successfully transplanted into an adult woman in Spain.

Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body

Animal stem cells, derived from non-human sources

The
past 10 years have also witnessed the production of novel stem cell
types, including piPSCs, R-NSCs, and VSELs. Together, this evidence
suggests that additional types of stem cells will likely be discovered,
each representing new opportunities for research product development.
Clearly, laboratory research into stem cell derivation, manipulation,
and application is rapidly expanding.

To facilitate research
resulting from these advances, a large and diverse stem cells products
market has emerged. Large companies selling stem cell research products
include Thermo Fisher Scientific (now merged with Life Technologies), BD
Biosciences, EMD Millipore, Sigma Aldrich, and STEMCELL Technologies,
as well as over one hundred other suppliers.

Stem cell services and mechanisms for in vivo and in vitro stem cell tracking

Expansion/differentiation services for stem cell media and RNAi

Stem cell lines

Furthermore,
to sell products in the stem cell market, it is critical to understand
the research applications for which stem cells are being studied. One
area of study is the use of stem cells to understand and treat birth
disorders. However, of greater interest to researchers is the potential
for use of stem cells in regenerative medicine to treat conditions
ranging from diabetes, to cardiovascular disease and neurological
disorders.

Pharmaceutical companies have intense interest in the
ability to use stem cells to improve drug target validation and
toxicology screening. Therefore, it is important for companies
interested in stem cell therapy applications to understand underlying
market forces, and in particular, to consider progressive areas of stem
cell research as opportunistic areas for drug and therapy development.
This report presents a range of topics of interest to these companies as
well, including how advances in stem research can reveal potential new
drug targets, improve methods of drug delivery, and provide personalized
treatment strategies.

The key areas that account for the majority of applied stem cell research include:

Regenerative Medicine - Reversal of injury or disease

Drug Target Validation and Drug Delivery - Treatment of disease

Toxicology Screening - Drug safety and efficacy assessment

Understanding and Treatment of Birth Disorders - Natal repair

This
2014 report provides detailed information on both basic and applied
stem cell research and research applications and includes an updated
list of global stem cell research centers by region.

Furthermore,
it is crucial for stem cell companies to understand the funding
environment that supports stem cell research. Currently, the U.S.
federal government is an important, although not dominant, source of
funding for stem cell research. The reason is that U.S. states are
spending almost as much as the federal government on stem cell research
and are actually spending more than the federal government on human
embryonic stem cell (hESC) research. Private sources also contribute a
huge amount of funding, with analysis of recent large gifts summing to
over $1.7 billion.

Growth in stem cell research has exploded in
the past decade, and so the market to supply stem cell research products
has grown to meet this huge demand. There are now over one million stem
cell researchers worldwide. In addition, there were only 17 stem cell
product companies as of 2006, and that has expanded to more than 100
today, a 6-fold increase.

The two most active areas of stem cell
research are mesenchymal stem cells, at 24.8% of all stem cell research,
and hematopoietic stem cells, at 24.1% - thus accounting for nearly
half of all stem cell research over a trailing twelve-month period. When
this analysis was last conducted using data from full-year 2012 (Jan 1,
2012 – Dec 31, 2012), hematopoietic stem cell research led mesenchymal
stem cell research, but that relationship has since switched, revealing
an interesting preference toward mesenchymal stem cell research among
the scientific community.

Also of interest is that for the
trailing-twelve months, induced pluripotent stem cell research activity
represented 8.9% of global stem cell research activity. When this
analysis was last conducted using full-year 2012 data (Jan 1, 2012 – Dec
31, 2012), induced pluripotent stem cell research activity represented
only 4.0% of global research activity, which means that a substantial
year-over-year shift has occurred. This report explores why this trend
has developed and how it will continue to evolve in the coming decade.

Not
surprisingly, trend analysis reveals rapid increases in stem cell
research activity over the past five years, specifically a scientific
publication rate increase of 9.9% per year.

The stem cell types with the greatest year-to-year increases in publication rates over a trailing five-year period include:

Mesenchymal stem cells

Induced pluripotent stem cells

Neural stem cells

While
hematopoietic stem cells represent the second most active area of stem
cell research, publication rates for these stem cell types have declined
in recent years. Because research activity by stem cell type has shown
divergent trends over the past few years, for research product companies
to be successful, they will need to understand underlying trends in
stem cell preferences, by cell type.

This market intelligence
report will advantageously position company to offer competitive
stem cell products to a rapidly growing, well-funded research community.

End-User Survey of Stem Cell Scientists:

A
key element of this report is a survey of stem cell researchers, for
the U.S. and worldwide. This 2014 survey reveals stem cell researcher
needs, technical preferences, key factors influencing buying decisions,
and more. It can be used to make effective product development
decisions, create targeted marketing messages, and produce higher
prospect-to-client conversion rates.

To benefit from this
lucrative product market, need to anticipate and serve the needs of clients or competitors will.

This survey reveals critical findings that include:

Prevalence of Stem Cell Research by Cell Type

Stem Cell Product Preferences

Most Commonly Utilized Stem Cell Markers, by Stem Cell Type

Most Commonly Utilized Stem Cell Antibodies, by Stem Cell Type

Preferred Providers of Stem Cell Antibodies

And Much More

Input Sources:

In
addition, the market intelligence contained in this report was compiled
using a broad range of sources, allowing the analysis to be thorough,
current, and cutting-edge. The findings presented here will improve strategic decision-making and will empower to make smarter
decisions, faster.

These input sources include:

Stem Cell Grant Funding Databases (NIH database, DoD database)

Stem Cell Patent Databases (USPTO)

Stem Cell Publication Databases (PubMed, Highwire Press)

Stem Cell Product Launch Announcements (Trade Journals, Google News)

International Surveys (Electronically distributed end-user surveys)

And More

Methodologies:

The following constitute the basis for our Research & Analysis:

Preliminary Research: Extensive secondary research based on preliminary market evaluations.

Fill-Gap Research: Selectively sampled and focused primary research as a fill-gap strategy.

Confirmatory Primary Research:
Presenting resulting data from companies or individuals participating
as research partners. Variations from derived data are adjusted to
reflect primary research based consensus.

Electronically Based End-User Surveys:
Distribution of electronically based end-user surveys to a panel of
industry representatives working within market segment(s) of interest.
Statistical filtering and analysis is performed on collected
user-response data.

Summary of Findings

Full-year
2013 analysis determines the size of the stem cell research products
market to be $3.22 billion, and the stem cell therapies market to be
$3.31 billion, for a total of $6.53 billion. In addition, both markets
are growing with double-digit growth. Producing stem cell research
products thus represents a massive profit opportunity for research
supply companies.

Additionally, the industry insights contained in
this market report will allow to dramatically increase profits
within the stem cell sector. Key findings within the report include:

Charts, Timelines, and Financials for the Stem Cell Products Market

Breakdown of Research Activity by Application, Species, and Tissue Source

Producing
stem cell products can involve complicated and confusing decisions, but
it doesn't have to. Claim this report to reveal the current and future
needs of customer base, in the most promising research areas and
within the most lucrative domestic and international markets.

About Us: ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. Not limited to the Stem Cell Market ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.